Simulations Plus announced that the U.S. Food and Drug Administration's Cosmetics Regulatory Science Branch has licensed its ADMET Predictor software platform to support computational research for modern cosmetic safety assessment. The contract expands the use of Simulations Plus technology within the FDA and underscores the growing role of predictive modeling and mechanistic science in regulatory research. ADMET Predictor combines artificial intelligence and machine learning with high-throughput pharmacokinetic modeling and predictive ADMET and toxicity assessments, giving FDA researchers a unified computational framework to evaluate both potential exposure and intrinsic hazard. The development supports the FDA's ongoing research into New Approach Methodologies. The announcement builds on Simulations Plus' 2024 research collaboration with the International Collaboration on Cosmetics Safety to evaluate physiologically based kinetic modeling approaches for animal-free safety assessment of cosmetics and other non-pharmaceutical ingredients. Chief Executive Officer Shawn O'Connor said the FDA's adoption expands the company's relationship with one of the world's leading regulatory organizations and highlights the versatility of its technology beyond pharmaceutical research.
Simulations Plus IncFDA Cosmetics Regulatory Science Branch licensed Simulations Plus' ADMET Predictor software, a concrete new customer adoption of its product.
